Jenna S Hynes1, Jessica M Sales2, Anandi N Sheth3, Eva Lathrop4, Lisa B Haddad5. 1. Emory University School of Medicine, Department of Gynecology and Obstetrics, 49 Jesse Hill Jr. Drive, NE, Faculty Office Building, Atlanta, GA 30322, USA. Electronic address: jenna.s.hynes@gmail.com. 2. Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA. Electronic address: jmcderm@emory.edu. 3. Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, 201 Dowman Drive, Atlanta, GA 30322, USA. Electronic address: ansheth@emory.edu. 4. Emory University School of Medicine, Department of Gynecology and Obstetrics, 49 Jesse Hill Jr. Drive, NE, Faculty Office Building, Atlanta, GA 30322, USA. Electronic address: elathro@emory.edu. 5. Emory University School of Medicine, Department of Gynecology and Obstetrics, 49 Jesse Hill Jr. Drive, NE, Faculty Office Building, Atlanta, GA 30322, USA. Electronic address: lisa.haddad@emory.edu.
Abstract
OBJECTIVE: High rates of sexually transmitted infections (STIs) and unintended pregnancy suggest a role for multipurpose prevention technologies (MPTs) designed to combine contraception and infection prophylaxis into one unified method. This study aims to determine factors associated with interest in MPTs among US women. STUDY DESIGN: We administered a national cross-sectional survey via MTurk. Eligibility criteria included female gender, age 18-29 years, residence in the USA, and sexual activity with a male partner in the past three months. In total, 835 surveys were suitable for analysis. Bivariable and multivariable logistic regressions were performed to determine factors associated with interest in MPTs. RESULTS: Eighty-three percent of women were interested in MPTs. Factors associated with interest included oral sex in the past three months (aOR 1.87, 95% CI 1.07, 3.53), recent use of oral contraceptive pills (OCPs; aOR 1.78, 95% CI 1.08, 2.93), HIV test within one year (aOR 2.10, 95% CI 1.29, 3.40), and increased STI worry score (aOR 1.98, 95% CI 1.36, 2.86). No use of contraception in the past three months was associated with decreased interest in MPTs (aOR 0.31, 95% CI 0.17, 0.58). HIV risk factors including race were not associated with MPT interest. CONCLUSION: Our data show that young, sexually active, US women are interested in MPTs. Women who used contraception, specifically OCPs, or evidenced concern for infection were most likely to be interested in such a product. Women reporting unsafe sexual habits were less likely to be interested, highlighting the importance of HIV/STI prevention education. IMPLICATIONS: Women in the USA are interested in multipurpose prevention technologies, particularly those women who currently use contraception or are concerned about their risk of infection. Our results emphasize the importance of moving forward with MPT development as well as continued HIV/STI prevention education.
OBJECTIVE: High rates of sexually transmitted infections (STIs) and unintended pregnancy suggest a role for multipurpose prevention technologies (MPTs) designed to combine contraception and infection prophylaxis into one unified method. This study aims to determine factors associated with interest in MPTs among US women. STUDY DESIGN: We administered a national cross-sectional survey via MTurk. Eligibility criteria included female gender, age 18-29 years, residence in the USA, and sexual activity with a male partner in the past three months. In total, 835 surveys were suitable for analysis. Bivariable and multivariable logistic regressions were performed to determine factors associated with interest in MPTs. RESULTS: Eighty-three percent of women were interested in MPTs. Factors associated with interest included oral sex in the past three months (aOR 1.87, 95% CI 1.07, 3.53), recent use of oral contraceptive pills (OCPs; aOR 1.78, 95% CI 1.08, 2.93), HIV test within one year (aOR 2.10, 95% CI 1.29, 3.40), and increased STI worry score (aOR 1.98, 95% CI 1.36, 2.86). No use of contraception in the past three months was associated with decreased interest in MPTs (aOR 0.31, 95% CI 0.17, 0.58). HIV risk factors including race were not associated with MPT interest. CONCLUSION: Our data show that young, sexually active, US women are interested in MPTs. Women who used contraception, specifically OCPs, or evidenced concern for infection were most likely to be interested in such a product. Women reporting unsafe sexual habits were less likely to be interested, highlighting the importance of HIV/STI prevention education. IMPLICATIONS: Women in the USA are interested in multipurpose prevention technologies, particularly those women who currently use contraception or are concerned about their risk of infection. Our results emphasize the importance of moving forward with MPT development as well as continued HIV/STI prevention education.
Authors: Jessica M Sales; Josh Spitalnick; Robin R Milhausen; Gina M Wingood; Ralph J DiClemente; Laura F Salazar; Richard A Crosby Journal: Health Educ Res Date: 2008-03-18
Authors: C Woodsong; P Musara; A Chandipwisa; E Montgomery; P Alleman; M Chirenje; T Chipato; F Martinson; I Hoffman Journal: BJOG Date: 2014-10 Impact factor: 6.531
Authors: Jenna S Hynes; Anandi N Sheth; Eva Lathrop; Jessica M Sales; Lisa B Haddad Journal: J Womens Health (Larchmt) Date: 2019-01-04 Impact factor: 2.681
Authors: Joseph G Rosen; Ju Nyeong Park; Kristin E Schneider; Rebecca Hamilton White; S Wilson Beckham; Jennifer L Glick; Katherine H A Footer; Susan G Sherman Journal: AIDS Behav Date: 2022-04-01
Authors: Nivedita L Bhushan; Petina Musara; Miriam Hartmann; Marie C D Stoner; Shweta R Shah; Josephine Nabukeera; Ivan Rukundo; Prisca Mutero; Megan A Lewis; Jeanna Piper; Mary Kate Shapley-Quinn; Juliane Etima; Alexandra M Minnis Journal: J Int AIDS Soc Date: 2022-10 Impact factor: 6.707
Authors: Emily Hoff; Zoe M Adams; Alyssa Grimshaw; Dawn A Goddard-Eckrich; Anindita Dasgupta; Sangini S Sheth; Jaimie P Meyer Journal: J Womens Health (Larchmt) Date: 2020-06-23 Impact factor: 2.681
Authors: Tomasz Osmałek; Anna Froelich; Barbara Jadach; Adam Tatarek; Piotr Gadziński; Aleksandra Falana; Kinga Gralińska; Michał Ekert; Vinam Puri; Joanna Wrotyńska-Barczyńska; Bozena Michniak-Kohn Journal: Pharmaceutics Date: 2021-06-15 Impact factor: 6.321
Authors: Alexandra M Minnis; Emily Krogstad; Mary Kate Shapley-Quinn; Kawango Agot; Khatija Ahmed; L Danielle Wagner; Ariane van der Straten Journal: Sex Reprod Health Matters Date: 2021-12
Authors: Deborah J Anderson; Joseph A Politch; Richard A Cone; Larry Zeitlin; Samuel K Lai; Philip J Santangelo; Thomas R Moench; Kevin J Whaley Journal: Biol Reprod Date: 2020-08-04 Impact factor: 4.161